Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - acetylcholine chloride, quantity: 10 mg/ml - diluent, not applicable - excipient ingredients: sodium acetate; magnesium chloride hexahydrate; potassium chloride; calcium chloride dihydrate; water for injections - miochol-e is used to obtain complete miosis of the iris in seconds after placement of the intraocular lens (iol) in cataract surgery; and in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.

Australia - English - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - agathosma betulina,echinacea angustifolia,elymus repens,glycyrrhiza glabra -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phentermine, quantity: 40 mg - capsule, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; liquid paraffin; erythrosine; titanium dioxide; sunset yellow fcf; sodium polystyrene sulfonate; iron oxide black; gelatin; silicon dioxide; sodium lauryl sulfate - phentamax - xr is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater. the treatment with phentamax - xr can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2) which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phentermine, quantity: 30 mg - capsule, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; liquid paraffin; titanium dioxide; iron oxide red; sodium polystyrene sulfonate; iron oxide black; gelatin; silicon dioxide; sodium lauryl sulfate - phentamax - xr is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater. the treatment with phentamax - xr can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2) which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phentermine, quantity: 15 mg - capsule, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; liquid paraffin; brilliant blue fcf; titanium dioxide; iron oxide yellow; sodium polystyrene sulfonate; iron oxide black; gelatin; silicon dioxide; sodium lauryl sulfate - phentamax - xr is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater. the treatment with phentamax - xr can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2) which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd -